Write For Us

Waiving the vaccine patent may come down to giving pharmaceutical companies incentives

Sponsored Post Vitamin D2 Canada Persia
104 Views
Published
President Joe Biden has given the initial nod for the U.S. to waive patent rights on COVID vaccines to boost international production. But there are real questions over how effective these moves would be, what other countries feel about it, and when this would translate into action. William Brangham discusses the matter with Rachel Silverman, a policy fellow at the Center for Global Development.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour

Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
Category
U.S. & Canada
Tags
Coronavirus, Coronavirus pandemic, coronavirus vaccine
Sign in or sign up to post comments.
Be the first to comment